Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data

Published:2010-06 Issue:3 Volume:43 Page:376-384
ISSN:1532-0464
Container-title:Journal of Biomedical Informatics
language:en
Short-container-title:Journal of Biomedical Informatics

Author:

Yang Xinan,Huang Yong,Crowson Matthew,Li Jianrong,Maitland Michael L.,Lussier Yves A.

Funder

NIH/NLM/NCI National Center for Multiscale Analyses of Genomic and Cellular Networks

NIH/NCRR Clinical & Translational Science Awards

Mentored Career Development award

Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference32 articles.

1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

2. Altered bone and mineral metabolism in patients receiving imatinib mesylate;Berman;N Engl J Med,2006

3. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate;Kerkela;Nat Med,2006

4. Terminal ballistics of kinase inhibitors: there are no magic bullets;Maitland;Ann Intern Med,2006

5. The protein kinase complement of the human genome;Manning;Science,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors;2024-08-08

2. Construction of a multi-tissue compound–target interaction network of Qingfei Paidu decoction in COVID-19 treatment based on deep learning and transcriptomic analysis;Journal of Bioinformatics and Computational Biology;2024-07-20

3. Prophylactic treatment with the c-Abl inhibitor, neurotinib, diminishes neuronal damage and the convulsive state in pilocarpine-induced mice;Cell Reports;2024-05

4. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors;BMC Cancer;2022-11-24

5. Decoding kinase-adverse event associations for small molecule kinase inhibitors;Nature Communications;2022-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3